Skip to main content
SpringerLink
Log in

Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The relationship between an extensive intraductal component (EIC) and recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy has not been clearly defined.

Methods: 133 patients with stage I or II breast cancer who underwent breast conservation therapy between 1978 and 1990 at The University of Texas M. D. Anderson Cancer Center were retrospectively studied. All pathology slides were reviewed to determine tumor size, nuclear grade, extent of intraductal component, number of positive lymph nodes, and histologic margins. EIC was defined as ductal carcinoma in situ (DCIS) occupying 25% or more of the area encompassed by the infiltrating tumor and DCIS present in grossly normal adjacent breast tissue.

Results: 110 patients are alive, and 23 have died, with a median follow-up of 7 years; 85 of 133 patients had an intraductal component, but only 18 had an EIC. Locoregional control and disease-free and overall survival were not adversely affected by the presence of an EIC. Five of 133 patients had a locoregional recurrence, but only one had an EIC.

Conclusions: EIC, if negative margins can be achieved, does not adversely affect disease-free or overall survival or local control rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, Mariani L, et al. Breast conservation is a safe method in patients with small cancers of the breast. Long-term results of three randomized trials on 1,973 patients.Eur J Cancer 1995;31A:1574–9.

    CAS  PubMed  Google Scholar 

  2. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalyses and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 1995;333:1456–61.

    CAS  PubMed  Google Scholar 

  3. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.N Engl J Med 1995;333:1444–55.

    Article  Google Scholar 

  4. Jacobson JA, Danforth DN, Cowan KH, D'Angelo T, Steinberg BM, Pierce L, Lippman ME, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.N Engl J Med 1995;332:907–11.

    Article  CAS  PubMed  Google Scholar 

  5. Stotter AT, McNeese MD, Ames FC, Oswald MJ, Ellerbrock NA. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer.Cancer 1989;64:2217–25.

    CAS  PubMed  Google Scholar 

  6. Harris JR, Connolly JL, Schnitt SJ, Cohen RB, Hellman S. Clinical pathologic study of early breast cancer treated by primary radiation therapy.J Clin Oncol 1983;1:184–9.

    CAS  PubMed  Google Scholar 

  7. Eberlein TJ, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris JR. Predictors of local recurrence following conservative breast surgery and radiation therapy.Arch Surg 1990;125:771–7.

    CAS  PubMed  Google Scholar 

  8. Clark DH, Martinez AA. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists.J Clin Oncol 1992;10:474–83.

    Google Scholar 

  9. Mate TP, Carter D, Fischer DB, Hartman PV, McKhann C, Merina M, Prosnitz LR, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma.Cancer 1986;58:1995–2002.

    CAS  PubMed  Google Scholar 

  10. Lindley R, Bulman A, Parsons P, Phillips R, Henry K, Ellis H. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local rumor excision and radical radiotherapy.Surgery 1989;105:13–20.

    CAS  PubMed  Google Scholar 

  11. Ahmed S, Tartter PI, Brower ST, Weiss SE, Brusco C, Bossolt K, Bleiweiss IJ, et al. Comparison of invasive cancers with and without extensive intraductal component.Breast Dis 1996;8:1–6.

    Google Scholar 

  12. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy.Cancer 1984;53:1049–57.

    CAS  PubMed  Google Scholar 

  13. Balch CM, Singletary E. Clinical decision-making in early breast cancer.Ann Surg 1993;217:207–25.

    CAS  PubMed  Google Scholar 

  14. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer 1994;74:1746–51.

    CAS  PubMed  Google Scholar 

  15. Harris JR, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT, Patterson WB, et al. The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy.Ann Surg 1985;201:164–9.

    CAS  PubMed  Google Scholar 

  16. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L, and collaborating NSABP investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol B-06). II. Relationship of local breast recurrence to multicentricity.Cancer 1986;57:1717–24.

    CAS  PubMed  Google Scholar 

  17. Fisher ER, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP Protocol B-06.Semin Surg Oncol 1992;8:161–6.

    CAS  PubMed  Google Scholar 

  18. Osteen RT, Connolly JL, Recht A, Silver B, Schnitt SJ, Harris JR. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer.Arch Surg 1987;122:1248–52.

    CAS  PubMed  Google Scholar 

  19. Schnitt SJ, Connolly JL, Khettry U, Mazoujian G, Brenner M, Silver B, Recht A, et al. Pathologic findings on the reexcision of the primary site in breast cancer patients considered for treatment by primary radiation therapy.Cancer 1987;59:675–81.

    CAS  PubMed  Google Scholar 

  20. Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, Love S, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy.Radiother Oncol 1990;19:29–41.

    Article  CAS  PubMed  Google Scholar 

  21. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer.Int J Radiat Oncol Biol Phys 1991;21:279–87.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, The University of Texas-Southwestern Medical Center, Dallas, Texas

    Thelma C. Hurd MD

  2. Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Nour Sneige MD

  3. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Gildy V. Babiera MD & S. Eva Singletary MD

  4. Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Pamela K. Allen MPH, Eric A. Strom MD & Marsha D. McNeese MD

Authors
  1. Thelma C. Hurd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nour Sneige MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pamela K. Allen MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric A. Strom MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marsha D. McNeese MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gildy V. Babiera MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Eva Singletary MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hurd, T.C., Sneige, N., Allen, P.K. et al. Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy. Annals of Surgical Oncology 4, 119–124 (1997). https://doi.org/10.1007/BF02303793

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303793

Key Words

Search

Navigation